Search - tctmd.com

Displaying 341 - 354 of 354

Sort: Relevancy | Date

News Daily News

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

October 18, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Daily News

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Jason Kahn

July 17, 2012

News Daily News

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

July 12, 2012

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

News Daily News

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Jason Kahn

September 26, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

GPIs in Elective PCI: Older Drugs Still Have a Role

February 27, 2011

Advertisement

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Guidelines Elevate Ticagrelor to First-line Antiplatelet Status in Unstable Angina

Meta-analysis: Adjusting Therapy Based on Platelet Function Results Improves Outcomes

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Double-Dose Clopidogrel Reduces Infarct Size in STEMI Patients

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Cilostazol Reduces Repeat Revascularizations for Long Lesions

GPIs in Elective PCI: Older Drugs Still Have a Role

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content